• CRISPR Therapeutics (NASDAQ:CRSP) Given Buy Rating at Needham & Company LLC

    Source: Buzz FX / 12 Feb 2025 08:41:10   America/New_York


    CRISPR Therapeutics (NASDAQ:CRSP) Given Buy Rating at Needham & Company LLC Written by MarketBeat February 12, 2025 Share Link copied to clipboard. CRISPR Therapeutics ( NASDAQ:CRSP - Get Free Report ) 's stock had its "buy" rating reissued
    Read more...
Share on,